TY800 Dose Escalation (Typhoid)

Clinical trial NCT00269295 · COMPLETED

Trial details

NCT number: NCT00269295
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Typhoid and Paratyphoid Fevers

Start date: 2006-02-01
Primary completion: 2007-01-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.